Legal Representation
Attorney
Sarah Anne Keefe
USPTO Deadlines
Application History
29 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 28, 2011 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Nov 28, 2011 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Mar 29, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 25, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 25, 2011 | EXT5 | S | SOU EXTENSION 5 FILED |
| Mar 25, 2011 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Oct 13, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Oct 12, 2010 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Oct 7, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 7, 2010 | EXT4 | S | SOU EXTENSION 4 FILED |
| Mar 25, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 23, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 23, 2010 | EXT3 | S | SOU EXTENSION 3 FILED |
| Mar 23, 2010 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Oct 26, 2009 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Oct 26, 2009 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Oct 9, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 9, 2009 | EXT2 | S | SOU EXTENSION 2 FILED |
| Apr 17, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 17, 2009 | EXT1 | S | SOU EXTENSION 1 FILED |
| Apr 17, 2009 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Oct 28, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Aug 5, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jul 16, 2008 | NPUB | O | NOTICE OF PUBLICATION |
| Jun 27, 2008 | ALIE | A | ASSIGNED TO LIE |
| Jun 27, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jun 26, 2008 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 26, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 27, 2008 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Chemicals used in industry, namely, recombinant human albumin to be added as a raw material for manufacturing cell culture media, diagnostic reagents, and biological medicines
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001